373 related articles for article (PubMed ID: 9558089)
21. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation.
Roman BL; Pollenz RS; Peterson RE
Toxicol Appl Pharmacol; 1998 Jun; 150(2):228-39. PubMed ID: 9653054
[TBL] [Abstract][Full Text] [Related]
22. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity.
Fernandez-Salguero PM; Hilbert DM; Rudikoff S; Ward JM; Gonzalez FJ
Toxicol Appl Pharmacol; 1996 Sep; 140(1):173-9. PubMed ID: 8806883
[TBL] [Abstract][Full Text] [Related]
23. Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Harrill JA; Layko D; Nyska A; Hukkanen RR; Manno RA; Grassetti A; Lawson M; Martin G; Budinsky RA; Rowlands JC; Thomas RS
J Appl Toxicol; 2016 Jun; 36(6):802-14. PubMed ID: 26278112
[TBL] [Abstract][Full Text] [Related]
24. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
[TBL] [Abstract][Full Text] [Related]
25. The thymus does not mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin-elicited alterations in bone marrow lymphocyte stem cells.
Frazier DE; Silverstone AE; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Feb; 124(2):242-7. PubMed ID: 8122269
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets.
Silverstone AE; Frazier DE; Fiore NC; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):248-59. PubMed ID: 7516097
[TBL] [Abstract][Full Text] [Related]
27. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium.
Greenlee WF; Dold KM; Irons RD; Osborne R
Toxicol Appl Pharmacol; 1985 Jun; 79(1):112-20. PubMed ID: 2996175
[TBL] [Abstract][Full Text] [Related]
28. Expression of functional aromatic hydrocarbon receptor and aromatic hydrocarbon nuclear translocator proteins in murine bone marrow stromal cells.
Lavin AL; Hahn DJ; Gasiewicz TA
Arch Biochem Biophys; 1998 Apr; 352(1):9-18. PubMed ID: 9521805
[TBL] [Abstract][Full Text] [Related]
29. Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation.
Kremer J; Gleichmann E; Esser C
J Immunol; 1994 Sep; 153(6):2778-86. PubMed ID: 8077682
[TBL] [Abstract][Full Text] [Related]
30. Generation of alphabeta T-cell receptor+ CD4- CD8+ cells in major histocompatibility complex class I-deficient mice upon activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kronenberg S; Lai Z; Esser C
Immunology; 2000 Jun; 100(2):185-93. PubMed ID: 10886394
[TBL] [Abstract][Full Text] [Related]
31. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity.
Fisher MT; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2004 Mar; 78(1):116-24. PubMed ID: 14718646
[TBL] [Abstract][Full Text] [Related]
32. T cell-specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution.
Tomita S; Jiang HB; Ueno T; Takagi S; Tohi K; Maekawa S; Miyatake A; Furukawa A; Gonzalez FJ; Takeda J; Ichikawa Y; Takahama Y
J Immunol; 2003 Oct; 171(8):4113-20. PubMed ID: 14530333
[TBL] [Abstract][Full Text] [Related]
33. Constitutively active aryl hydrocarbon receptor expressed in T cells increases immunization-induced IFN-gamma production in mice but does not suppress T(h)2-cytokine production or antibody production.
Nohara K; Suzuki T; Ao K; Murai H; Miyamoto Y; Inouye K; Pan X; Motohashi H; Fujii-Kuriyama Y; Yamamoto M; Tohyama C
Int Immunol; 2009 Jul; 21(7):769-77. PubMed ID: 19461128
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol (3,5,4'-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Singh NP; Singh US; Nagarkatti M; Nagarkatti PS
Mol Nutr Food Res; 2011 Feb; 55(2):209-19. PubMed ID: 20715097
[TBL] [Abstract][Full Text] [Related]
35. 2,3,7,8-Tetrachlorodibenzo-p-dioxin prompted differentiation to CD4
Cho MK; Park JG; Iwata H; Kim EY
Ecotoxicol Environ Saf; 2021 Mar; 211():111947. PubMed ID: 33503546
[TBL] [Abstract][Full Text] [Related]
36. Alterations of thymocyte development, thymic emigrants and peripheral T cell population in rats exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin.
Nohara K; Ushio H; Tsukumo S; Kobayashi T; Kijima M; Tohyama C; Fujimaki H
Toxicology; 2000 Apr; 145(2-3):227-35. PubMed ID: 10771146
[TBL] [Abstract][Full Text] [Related]
37. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
[TBL] [Abstract][Full Text] [Related]
38. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice.
Lin TM; Ko K; Moore RW; Buchanan DL; Cooke PS; Peterson RE
J Toxicol Environ Health A; 2001 Oct; 64(4):327-42. PubMed ID: 11693491
[TBL] [Abstract][Full Text] [Related]
39. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
40. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
